life-threatening Tagged Articles
Dialysis solutions recalled due to potential contamination
Baxter International is recalling two lots of Dianeal Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) because oxidized stainless steel, garment fiber and PVC particulate matter was present during the manufacturing process and seen floating in
Injectable skin and blood infection treatment recalled
Certain lots of the injectable drug Cubicin (daptomycin), used to treat skin infections and certain blood stream infections, are being recalled because of the potential presence of glass particles in vials. The administration of glass particulate, if present in an
Pre-diabetes diagnoses benefit drug companies more than patients
Non-diabetics with higher-than-recommended blood sugar levels and thus at risk for developing type 2 diabetes are considered pre-diabetic, however classifying large numbers of people with pre-diabetes offers more benefit to drug companies than those diagnosed with the condition, researchers argue.
Hospira recalls intravenous fluid replacement due to mold contamination
Hospira Inc. is issuing a nationwide recall of one lot of Lactated Ringers and 5 % Dextrose Injection because a bag of the intravenous fluid replacement was found to be contaminated with mold.
Testosterone therapy prescribed generously despite potentially dangerous side effects
The number of prescriptions for testosterone replacement therapy for men 40 years of age and older has risen 300 percent between 2001 and 2011, and a quarter of the most recent testosterone therapy users have never had their blood levels
MBL granted A-Rod therapeutic use exemption for testosterone therapy
Yankees third baseman Alex Rodriguez, best known as A-Rod, was using a testosterone treatment during the 2007 season under a therapeutic use exemption from Major League Baseball, according to a new book titled Blood Sport: Alex Rodriguez, Biogenesis and the
Antidepressant use during pregnancy remains controversial issue
A new study suggesting that there is no increased risk of heart defects in newborns exposed to antidepressants in the first three months of gestation is being criticized by medical experts.
Drug to treat rare disorders recalled for third time since August
Alexion Pharmaceuticals has issued the third recall since August of its sole approved drug Soliris after visible particles were seen in some vials during periodic testing. If injected, the particles could pose safety risks to patients in two general areas
Statins fail to offer benefit to patients with serious lung diseases
Studies using statin medication to treat patients with chronic obstructive pulmonary disease (COPD) or acute respiratory distress syndrome (ARDS) failed to show any respiratory benefit to patients and as a result were halted early. The research was conducted after observational
Skin reaction warning added to Excedrin Migraine over-the-counter pain reliever
Safety labels of over-the-counter pain reliever Excedrin Migraine have been updated to include a warning for serious skin reactions, the Food and Drug Administration (FDA) announced. Symptoms of this allergic reaction include skin reddening, blisters and rash. Consumers who use